Judge Gives Final OK To $35M GSK Flonase Settlement

Law360, New York (June 19, 2013, 5:00 PM EDT) -- A Pennsylvania federal judge Wednesday gave final approval to a $35 million settlement ending a class action alleging GlaxoSmithKline PLC used improper means to block its rivals from bringing generic versions of its allergy medication Flonase to market.

U.S. District Judge Anita B. Brody said the settlement was “fair, reasonable and adequate” to a class of indirect purchasers of Flonase and other plaintiffs who alleged GSK abused the U.S. Food and Drug Administration's citizens petition process to delay entry of lower-cost alternatives to its prescription nasal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.